Trials / Completed
CompletedNCT06012669
Effects of Lactoferrin at Two Doses vs. Active Control on Markers of Immune Function
A Randomized, Double-blind, Controlled, Parallel-arm Trial to Assess the Effects of Lactoferrin at Two Doses vs. Active Control on Markers of Immune Function in Healthy Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- Midwest Center for Metabolic and Cardiovascular Research · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the impact of 28-day supplementation with high-dose human recombinant lactoferrin, low-dose human recombinant lactoferrin, and an active control product formulated with bovine lactoferrin on indicators of immunity in healthy males and females.
Detailed description
Samples will be retained for possible analyses such as lactoferrin absorption, distribution, metabolism, and excretion (ADME) and gut microbiota.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | High dose Human Lactoferrin | Dietary Supplement and Food Ingredient |
| DIETARY_SUPPLEMENT | Low dose Human Lactoferrin | Dietary Supplement and Food Ingredient |
| DIETARY_SUPPLEMENT | Active Control Bovine Lactoferrin | Dietary Supplement and Food Ingredient |
Timeline
- Start date
- 2023-09-06
- Primary completion
- 2023-12-27
- Completion
- 2023-12-27
- First posted
- 2023-08-25
- Last updated
- 2025-06-11
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06012669. Inclusion in this directory is not an endorsement.